Suchergebnisse - "Nelson, Cara H"

PubPharm (16)

1

Semi-Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA

enthalten in: Clinical pharmacology and therapeutics | 2022

von Meng, A. | Humeniuk, R. | Jürgensmeier, J. | +10

2

Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants

enthalten in: Clinical pharmacology in drug development | 2022

von Anderson, K. | Nelson, C. | Gong, Q. | +3

3

Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants

enthalten in: Clinical Pharmacology in Drug Development | 2022

von Anderson, K. | Nelson, C. | Gong, Q. | +3

4

Semi‐Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Meng, A. | Humeniuk, R. | Jürgensmeier, J. | +10

5

Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2020

von Nelson, C. | Etchevers, K. | Yi, S. | +5

6

Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2020

von Nelson, C. | Etchevers, K. | Yi, S. | +5

7

Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2020

von Nelson, C. | Etchevers, K. | Yi, S. | +5

8

Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2020

von Nelson, C. | Etchevers, K. | Yi, S. | +5

9

Direct protein-protein interactions and substrate channeling between cellular retinoic acid binding proteins and CYP26B1

enthalten in: FEBS letters | 2016

von Nelson, C. | Peng, C. | Lutz, J. | +3

10

Direct protein-protein interactions and substrate channelling between cellular retinoic acid binding proteins and CYP26B1

enthalten in: FEBS letters | 2016

von Nelson, C. | Peng, C. | Lutz, J. | +3